Primary |
Alopecia |
13.0% |
Alopecia Totalis |
11.1% |
Psoriasis |
11.1% |
Drug Use For Unknown Indication |
9.3% |
Dermatosis |
7.4% |
Alopecia Areata |
5.6% |
Dermatitis |
5.6% |
Eczema |
5.6% |
Lichen Planus |
3.7% |
Product Used For Unknown Indication |
3.7% |
Pruritus |
3.7% |
Restless Legs Syndrome |
3.7% |
Seasonal Allergy |
3.7% |
Asthma |
1.9% |
Blood Cholesterol Increased |
1.9% |
Contraception |
1.9% |
Dandruff |
1.9% |
Depression |
1.9% |
Genital Herpes |
1.9% |
Hair Disorder |
1.9% |
|
Drug Ineffective |
13.2% |
Application Site Pain |
9.4% |
Alopecia |
7.5% |
Inappropriate Schedule Of Drug Administration |
7.5% |
Product Quality Issue |
7.5% |
Dizziness |
5.7% |
Growth Retardation |
5.7% |
Off Label Use |
5.7% |
Pruritus |
5.7% |
Accidental Exposure |
3.8% |
Burning Sensation |
3.8% |
Dry Skin |
3.8% |
Eye Irritation |
3.8% |
Headache |
3.8% |
Skin Irritation |
3.8% |
Adverse Event |
1.9% |
Cerebrovascular Accident |
1.9% |
Drug Administration Error |
1.9% |
Dysgeusia |
1.9% |
Epistaxis |
1.9% |
|
Secondary |
Alopecia Areata |
21.4% |
Asthma |
7.1% |
Contraception |
7.1% |
Dermatitis |
7.1% |
Eczema |
7.1% |
Genital Herpes |
7.1% |
Iron Metabolism Disorder |
7.1% |
Iron Overload |
7.1% |
Leukaemia |
7.1% |
Psoriasis |
7.1% |
Seasonal Allergy |
7.1% |
Seborrhoeic Dermatitis |
7.1% |
|
Off Label Use |
18.2% |
Skin Exfoliation |
18.2% |
Blood Glucose Increased |
9.1% |
Drug Ineffective |
9.1% |
Growth Retardation |
9.1% |
Inappropriate Schedule Of Drug Administration |
9.1% |
Product Quality Issue |
9.1% |
Vomiting |
9.1% |
Wrong Technique In Drug Usage Process |
9.1% |
|
Concomitant |
Product Used For Unknown Indication |
16.4% |
Psoriasis |
15.9% |
Drug Use For Unknown Indication |
13.7% |
Crohn's Disease |
9.5% |
Scleroderma |
6.0% |
Psoriatic Arthropathy |
5.0% |
Oral Disorder |
4.0% |
Pain |
3.5% |
Eczema |
3.2% |
Depression |
2.7% |
Anxiety |
2.5% |
Hypercholesterolaemia |
2.5% |
Hypertension |
2.5% |
Antibiotic Therapy |
2.2% |
Gastrooesophageal Reflux Disease |
2.2% |
Asthma |
2.0% |
Hypersensitivity |
1.7% |
Antidepressant Therapy |
1.5% |
Antitussive Therapy |
1.5% |
Prostatomegaly |
1.5% |
|
Urinary Tract Infection |
11.5% |
Weight Decreased |
11.5% |
Lupus-like Syndrome |
9.6% |
Crohn's Disease |
7.7% |
Electrocardiogram Qt Prolonged |
5.8% |
Urinary Tract Infection Pseudomonal |
5.8% |
Urine Leukocyte Esterase Positive |
5.8% |
Abdominal Pain |
3.8% |
Headache |
3.8% |
Ileal Stenosis |
3.8% |
Nasopharyngitis |
3.8% |
Psoriasis |
3.8% |
Red Blood Cell Count Decreased |
3.8% |
Tremor |
3.8% |
Unevaluable Event |
3.8% |
Wheezing |
3.8% |
Acne |
1.9% |
Aortic Rupture |
1.9% |
Asthenia |
1.9% |
Blood Testosterone Decreased |
1.9% |
|